Valuation: Certara, Inc.

Market Cap 1.43B 1.27B 1.18B 1.07B 2.02B 136B 2.05B 14.17B 5.56B 70.85B 5.36B 5.25B 227B P/E 2026 *
-42.3x
P/E 2027 * 158x
Enterprise Value 1.49B 1.33B 1.23B 1.12B 2.1B 141B 2.13B 14.76B 5.8B 73.81B 5.59B 5.47B 236B EV / Sales 2026 *
3.93x
EV / Sales 2027 * 3.63x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day+0.85%
1 week+3.50%
Current month+2.72%
1 month+12.23%
3 months+36.36%
6 months+51.93%
Current year+7.26%
1 week 9.22
Extreme 9.215
9.94
1 month 8.42
Extreme 8.425
10.19
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
12.94
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 31/12/2025
Director of Finance/CFO 53 14/07/2026
Chief Tech/Sci/R&D Officer - 30/07/2025
Director TitleAgeSince
Chairman 72 30/11/2021
Director/Board Member 68 31/12/2012
Director/Board Member 59 31/07/2017
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Financial Officer

63,532 0.0416%
15/07/26 Other

Chief Financial Officer

191,850 0.1233%
01/06/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%+3.50%-21.05%-31.27% 1.43B
+0.84%-0.29%+3.88%+61.62% 3,928B
+4.36%-7.13%+8.98%+1,028.78% 447B
+1.06%-8.35%-55.51%+19.71% 389B
+1.45%-17.15%+66.89%+165.52% 280B
+0.31%+4.38%-13.47%+64.97% 259B
+0.31%-17.07%+88.26%+385.86% 233B
+2.39%+3.19%-19.57%+31.98% 147B
+1.40%-11.94%+105.54%+197.38% 124B
+0.77%+1.99%-25.86%-55.71% 95.43B
Average +0.76%-6.16%+13.81%+186.88% 590.38B
Weighted average by Cap. +0.10%-3.81%+6.98%+150.18%

Financials

2026 *2027 *
Net sales 379M 338M 313M 285M 534M 35.94B 542M 3.75B 1.47B 18.77B 1.42B 1.39B 60.02B 388M 346M 321M 292M 548M 36.85B 556M 3.85B 1.51B 19.25B 1.46B 1.43B 61.54B
Net income -30.79M -27.46M -25.44M -23.14M -43.42M -2.92B -44.1M -305M -120M -1.53B -116M -113M -4.88B 4.22M 3.77M 3.49M 3.17M 5.95M 401M 6.05M 41.85M 16.44M 209M 15.84M 15.51M 669M
Net Debt 59.79M 53.32M 49.39M 44.94M 84.31M 5.67B 85.64M 593M 233M 2.96B 224M 220M 9.48B -19.92M -17.77M -16.46M -14.97M -28.1M -1.89B -28.54M -197M -77.55M -987M -74.75M -73.17M -3.16B
Projected Income Statement - Annual - Certara, Inc.
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
19/10/26 US$9.450 +0.85% 1,501,148
16/10/26 US$9.370 -3.00% 2,359,261
15/10/26 US$9.660 +3.21% 1,658,188
14/10/26 US$9.360 -2.50% 1,821,434
13/10/26 US$9.600 +3.90% 2,905,637
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Certara, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
9.450USD
Average target price
9.168USD
Spread / Average Target
-2.98%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Certara, Inc.
  1. Stock Market
  2. Stocks
  3. CERT Stock